As of close of business last night, Chimerix Inc’s stock clocked out at $1.15, down -7.26% from its previous closing price of $1.24. In other words, the price has decreased by -$0.0900 from its previous closing price. On the day, 644014 shares were traded. CMRX stock price reached its highest trading level at $1.3000 during the session, while it also had its lowest trading level at $1.1500.
Ratios:
To gain a deeper understanding of CMRX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.93 and its Current Ratio is at 12.93. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on May 23, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $7.
On April 29, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $20.Maxim Group initiated its Buy rating on April 29, 2021, with a $20 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Feb 14 when Jakeman David sold 2,660 shares for $1.04 per share. The transaction valued at 2,777 led to the insider holds 141,232 shares of the business.
LaSpaluto Michelle sold 1,940 shares of CMRX for $2,023 on Feb 14. The CHIEF FINANCIAL OFFICER now owns 110,999 shares after completing the transaction at $1.04 per share. On Feb 14, another insider, Andriole Michael T., who serves as the PRESIDENT AND CEO of the company, sold 1,744 shares for $1.04 each. As a result, the insider received 1,809 and left with 447,021 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CMRX now has a Market Capitalization of 109.34M and an Enterprise Value of -83.67M. For the stock, the TTM Price-to-Sale (P/S) ratio is 90.46 while its Price-to-Book (P/B) ratio in mrq is 0.49. Its current Enterprise Value per Revenue stands at -73.78 whereas that against EBITDA is 0.87.
Stock Price History:
Over the past 52 weeks, CMRX has reached a high of $1.77, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is 0.9904, while the 200-Day Moving Average is calculated to be 1.0752.
Shares Statistics:
It appears that CMRX traded 401.63K shares on average per day over the past three months and 514.77k shares per day over the past ten days. A total of 88.05M shares are outstanding, with a floating share count of 79.04M. Insiders hold about 11.08% of the company’s shares, while institutions hold 46.19% stake in the company. Shares short for CMRX as of Feb 15, 2024 were 1.24M with a Short Ratio of 3.10, compared to 1.14M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.40% and a Short% of Float of 1.47%.
Earnings Estimates
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.24 for the current quarter, with a high estimate of -$0.18 and a low estimate of -$0.27, while EPS last year was -$0.24. The consensus estimate for the next quarter is -$0.22, with high estimates of -$0.16 and low estimates of -$0.25.
Analysts are recommending an EPS of between -$0.9 and -$0.99 for the fiscal current year, implying an average EPS of -$0.96. EPS for the following year is -$0.82, with 7 analysts recommending between -$0.6 and -$0.96.
Revenue Estimates
A total of 7 analysts have provided revenue estimates for CMRX’s current fiscal year. The highest revenue estimate was $670k, while the lowest revenue estimate was $300k, resulting in an average revenue estimate of $370k. In the same quarter a year ago, actual revenue was $33.82M, down -98.90% from the average estimate.
